Want to join the conversation?
$JEC's 4Q15 revenue on constant currency grew 2%. The management of costs resulted in adjusted EPS of $0.80, which included a negative FX impact of 4% from 4Q14. The company's lower SG&A costs were backed by higher benefits of restructuring over the course of the year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.